UJUlrike John

Ulrike John

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ulrike John has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • Joachim Misselwitz

    Pediatric Nephrology, Friedrich Schiller University Children's Hospital, Kochstraße 2, D-07740 Jena, 2Pediatric Nephrology, University Children's Hospital, Albert-Schweitzer-Straße 22, D-48149 Münster and 3Pediatric Nephrology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany

    3 shared publications
  • Andreas Stallmach

    Department of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital, Jena, Germany

    1 shared publication
  • Anne Schulze Everding

    1 shared publication
  • Axel Dost

    Department of Pediatrics, University Hospital Jena, Jena, Germany

    1 shared publication
  • Baerbel Tautkus

    Jena University Hospital, Institute of Biochemistry I, Nonnenplan 2-4, 07743 Jena, Germany

    1 shared publication
  • Benjamin Giszas

    Klinik für Innere Medizin IV (Gastroenterologie, Hepatologie, Infektiologie, Interdisziplinäre Endoskopie), Universitätsklinikum Jena

    1 shared publication

Latest Publications

  • Open Access

    Preclinical Detection of Early Glomerular Injury in Children with Kidney Diseases—Independently of Usual Markers of Kidney Impairment and Inflammation

    by Heidrun Rhode, Baerbel Tautkus, Friederike Weigel, Julia Schitke, Oliver Metzing, Jan Boeckhaus, Wieland Kiess, Oliver Gross, Axel Dost, Ulrike John-Kroegel

    Glomerular kidney diseases typically begin insidiously and can progress to end stage kidney failure. Early onset of therapy can slow down disease progression. Early diagnosis is required to ensure such timely therapy. The goal of our study was to evaluate protein biomarkers (BMs) for common nephropathies that have been described for children with Alport syndrome. Nineteen candidate BMs were determined by commercial ELISA in children with congenital anomalies of the kidneys and urogenital tract, inflammatory kidney injury, or diabetes mellitus. It is particularly essential to search for kidney disease BMs in children because they are a crucial target group that likely exhibits early disease stages and in which misleading diseases unrelated to the kidney are rare. Only minor differences in blood between affected individuals and controls were found. However, in urine, several biomarker candidates alone or in combination seemed to be promising indicators of renal injury in early disease stages. The BMs of highest sensitivity and specificity were collagen type XIII, hyaluronan-binding protein 2, and complement C4-binding protein. These proteins are unrelated to inflammation markers or to risk factors for and signs of renal failure. In conclusion, our study evaluated several strong candidates for screening for early stages of kidney diseases and can help to establish early nephroprotective regimens.


  • Akutes Nierenversagen und Nierenersatztherapie beim Neugeborenen

    by Ulrike John-Kroegel, Friederike Weigel

    Das Auftreten eines akuten Nierenversagens in der Neonatalperiode wurde bisher deutlich unterschätzt. Erst in den letzten Jahren zeigen Forschungsergebnisse, dass vor allem Folgeschäden im weiteren Leben des Kindes durch eine verminderte Nierenfunktion bis hin zur Nierenersatztherapie eine bedeutende Rolle spielen. Der Beitrag stellt die wesentlichen Erkenntnisse im Hinblick auf Diagnostik, Risikofaktoren, Prävention und rechtzeitige Therapie vor. Article published online: 15 May 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Graft function and health status in renal transplant recipients hospitalized for COVID-19: a single center case series

    by Benjamin Giszas, Johannes Ruhe, Mandy Schlosser, Philipp Alexander Reuken, Ulrike John-Kroegel, Andreas Stallmach, Gunter Wolf


  • Blood pressure in children with renal cysts and diabetes syndrome

    by Tomáš Seeman, Friederike Weigel, Kveta Blahova, Filip Fencl, Stepanka Pruhova, Katharina Hermes, Richard Klaus, Bärbel Lange-Sperandio, Veit Grote, Ulrike John-Kroegel

    Cystic kidney diseases such as autosomal recessive or dominant polycystic kidney disease (ARPKD and ADPKD) are associated with high prevalence of arterial hypertension. On the contrary, studies on hypertension in children with renal cysts and diabetes (RCAD) syndrome caused by abnormalities in the HNF1B gene are rare. Therefore, the primary aim of our study was to investigate the prevalence of high blood pressure in children with RCAD syndrome due to HNF1B gene abnormalities and secondary to search for possible risk factors for development of high blood pressure. Data on all children with genetically proven RCAD syndrome from three pediatric nephrology tertiary centers were retrospectively reviewed (office blood pressure (BP), ambulatory blood pressure monitoring (ABPM), creatinine clearance, renal ultrasound, echocardiography, albuminuria/proteinuria). High blood pressure was defined as BP ≥ 95th percentile of the current ESH 2016 guidelines and/or by the use of antihypertensive drugs. Thirty-two children with RCAD syndrome were investigated. Three children received ACE inhibitors for hypertension and/or proteinuria. High blood pressure was diagnosed using office BP in 22% of the children (n = 7). In the 7 performed ABPM, 1 child (14%) was diagnosed with hypertension and one child with white-coat hypertension. Creatinine clearance, proteinuria, albuminuria, body mass index, enlargement, or hypodysplasia of the kidneys and prevalence of HNF1B-gene deletion or mutation were not significantly different between hypertensive and normotensive children. Conclusion: High blood pressure is present in 22% of children with RCAD syndrome. What is Known: • Arterial hypertension is a common complication in children with polycystic kidney diseases. What is New: • High office blood pressure is present in 22% and ambulatory hypertension in 14% of children with renal cyst and diabetes (RCAD) syndrome.


  • Diagnostik angeborener Harntransportstörungen

    by Pd Dr. U. John, H.-J. Mentzel, S. Weber


  • Pränatal diagnostizierte Nieren- und Harntraktfehlbildungen/Uropathien

    by D. Schlembach, F. Eckoldt, H.J.M. Mentzel, U. John

    Zusammenfassung: Kongenitale Anomalien von Nieren und Harntrakt (CAKUT) sind im Rahmen der fetalen Ultraschalldiagnostik mit 40 % die am häufigsten erhobenen Befunde. Aufgrund unterschiedlicher Diagnosen und Ausprägung dieser Erkrankungen ist zwischen anatomischen und funktionell harmlosen Varianten und Anomalien mit dem Risiko einer progredienten Nierenschädigung zu unterscheiden. In der Mehrzahl handelt es sich um „harmlose“ Pyelektasien, die keiner weiteren invasiven Diagnostik bedürfen. Schwere obstruktive bilaterale Erkrankungen sind selten. Im Vordergrund der Diagnostik steht die Ultraschalluntersuchung, ergänzt durch andere bildgebende Methoden und Funktionsuntersuchungen (Miktionszysturografie, Miktionsurosonografie, funktionelles MRT und Szintigrafie). Das perinatologische Konsil bietet den Eltern durch die multidisziplinäre Bewertung eine umfassende fachkompetente Aufklärung über die Prognose, Diagnostik und Therapie nach der Geburt. Der Beitrag beschreibt anhand verschiedener nephrourologischer Anomalien die Strategie der prä- und postnatalen Diagnostik und konservativen und operativen Behandlungsmöglichkeiten.

  • Konzept zur Verbesserung der Adhärenz bei jugendlichen Erwachsenen nach Nierentransplantation

    by U. John, G. Offner, K. Breuch, M. Oldhafer

    Der Prozess des Transfers jugendlicher chronisch kranker Patienten in die Erwachsenenbetreuung findet bisher nur unzureichend Beachtung. Für pädiatrische Patienten nach Nierentransplantation stellt diese Periode, die mit einem Transplantatverlust von über 20% assoziiert ist, jedoch ein besonderes Risiko im Hinblick auf die Langzeitfunktion der Niere dar. Einer der wesentlichen Faktoren, die zu Transplantatabstoßung oder -verlust bei Jugendlichen führen, ist die fehlende Adhärenz bezüglich der Einnahme immunsuppressiver Medikamente. Der Übergang in die Erwachsenenbetreuung ist deshalb ein Anliegen beider Bereiche, der pädiatrischen wie auch der Erwachsenenversorgung. Das setzt jedoch eine effektive Zusammenarbeit an dieser Schnittstelle voraus. Der vorliegende Beitrag erläutert medizinische und psychologische Risikofaktoren bzw. Barrieren, die diesen Prozess beeinflussen. Darüber hinaus wird ein speziell entwickeltes Trainingsprogramm für jugendliche Patienten mit terminaler Niereninsuffizienz vorgestellt, das den Transferprozess in die Erwachsenenbetreuung unterstützt. Transition to adult care is a generic issue for subspecialties dealing with chronic illness and has received little attention to date. The transition from pediatric to adult care for renal transplant recipients is recognized as a high-risk period for poor graft outcome associated with more than 20% graft loss. Non-adherence to immunosuppressive medications is one of the most important factors contributing to graft loss during this period. Transition is, therefore, a concern of both pediatric and adult providers, and medical improvements in this area will require more effective collaboration at this interface. This report explores medical and psychological risk factors and barriers during the transition process. In addition, a specially developed coaching concept for young adults is presented intended to assist adolescents with early childhood end-stage renal disease in the transition from pediatric to adult care.